“Drugs to avoid” to improve quality use of medicines: how is Australia faring?

Abstract Background Each year, the French independent bulletin Prescrire publishes a list of medicines, “Drugs to avoid”, that should not be used in clinical practice as their risk-to-benefit ratio is unfavourable. This study assessed the market approval, reimbursement and use of these medicines in...

Full description

Bibliographic Details
Main Authors: Agnes Vitry, Barbara Mintzes
Format: Article
Language:English
Published: BMC 2021-07-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
Online Access:https://doi.org/10.1186/s40545-021-00346-3